Production (Stage)
E
Altamira Therapeutics Ltd. CYTOF
$0.10 $0.00060.60% OTC PK
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024
Revenue -- --
Total Other Revenue -- --
Total Revenue -- --
Cost of Revenue -- --
Gross Profit -- --
SG&A Expenses 0.00% -39.29%
Depreciation & Amortization -- --
Other Operating Expenses 0.00% -7.02%
Total Operating Expenses 0.00% -25.11%
Operating Income 0.00% 25.11%
Income Before Tax 0.00% 5.11%
Income Tax Expenses -- --
Earnings from Continuing Operations 0.00% 5.11%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income 0.00% 5.11%
EBIT 0.00% 25.11%
EBITDA -- --
EPS Basic 0.00% 45.75%
Normalized Basic EPS 0.00% 45.74%
EPS Diluted 0.00% 45.75%
Normalized Diluted EPS 0.00% 45.74%
Average Basic Shares Outstanding 0.00% 74.89%
Average Diluted Shares Outstanding 0.00% 74.89%
Dividend Per Share -- --
Payout Ratio -- --